Page last updated: 2024-09-03

mozavaptan and hydrochlorothiazide

mozavaptan has been researched along with hydrochlorothiazide in 1 studies

Compound Research Comparison

Studies
(mozavaptan)
Trials
(mozavaptan)
Recent Studies (post-2010)
(mozavaptan)
Studies
(hydrochlorothiazide)
Trials
(hydrochlorothiazide)
Recent Studies (post-2010) (hydrochlorothiazide)
1658246,9212,1651,262

Protein Interaction Comparison

ProteinTaxonomymozavaptan (IC50)hydrochlorothiazide (IC50)
Carbonic anhydrase 2Homo sapiens (human)5.4954

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bankir, L; Barberis, C; Brossard, G; Chicot, D; Foulon, L; Galindo, G; Garcia, C; Garcia, G; Guillon, G; Jard, S; Lacour, C; Le Fur, G; Maffrand, JP; Marty, E; Nisato, D; Pouzet, B; Raufaste, D; Serradeil-Le Gal, C; Valette, G; Vilain, P1

Other Studies

1 other study(ies) available for mozavaptan and hydrochlorothiazide

ArticleYear
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
    The Journal of clinical investigation, 1996, Dec-15, Volume: 98, Issue:12

    Topics: Adenylyl Cyclases; Administration, Oral; Adrenal Glands; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Autoradiography; Benzazepines; Binding, Competitive; Furosemide; Hydrochlorothiazide; Kidney; Molecular Structure; Morpholines; Potassium; Rats; Sodium; Spiro Compounds; Urine

1996